- United Kingdom
- /
- Healthtech
- /
- AIM:EMIS
EMIS Group plc (LON:EMIS) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
EMIS Group plc (LON:EMIS) last week reported its latest annual results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. EMIS Group reported UK£159m in revenue, roughly in line with analyst forecasts, although statutory earnings per share (EPS) of UK£0.48 beat expectations, being 3.6% higher than what the analysts expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
See our latest analysis for EMIS Group
After the latest results, the four analysts covering EMIS Group are now predicting revenues of UK£164.3m in 2021. If met, this would reflect an okay 3.0% improvement in sales compared to the last 12 months. Statutory per share are forecast to be UK£0.49, approximately in line with the last 12 months. Before this earnings report, the analysts had been forecasting revenues of UK£164.3m and earnings per share (EPS) of UK£0.47 in 2021. So the consensus seems to have become somewhat more optimistic on EMIS Group's earnings potential following these results.
There's been no major changes to the consensus price target of UK£12.51, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic EMIS Group analyst has a price target of UK£13.50 per share, while the most pessimistic values it at UK£11.52. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.
Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's clear from the latest estimates that EMIS Group's rate of growth is expected to accelerate meaningfully, with the forecast 3.0% annualised revenue growth to the end of 2021 noticeably faster than its historical growth of 0.009% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 32% per year. It seems obvious that, while the future growth outlook is brighter than the recent past, EMIS Group is expected to grow slower than the wider industry.
The Bottom Line
The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around EMIS Group's earnings potential next year. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting sales are tracking in line with expectations - although our data does suggest that EMIS Group's revenues are expected to perform worse than the wider industry. The consensus price target held steady at UK£12.51, with the latest estimates not enough to have an impact on their price targets.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple EMIS Group analysts - going out to 2023, and you can see them free on our platform here.
You can also see our analysis of EMIS Group's Board and CEO remuneration and experience, and whether company insiders have been buying stock.
If you’re looking to trade EMIS Group, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
Valuation is complex, but we're here to simplify it.
Discover if EMIS Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisThis article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About AIM:EMIS
EMIS Group
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom.
Flawless balance sheet with proven track record.